Luca Issi
Stock Analyst at RBC Capital
(2.21)
# 2,777
Out of 4,969 analysts
204
Total ratings
44.72%
Success rate
-5.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintains: Outperform | $70 → $80 | $60.49 | +32.25% | 9 | Sep 4, 2025 | |
| ARGX argenx SE | Initiates: Outperform | $850 | $740.13 | +14.84% | 1 | Aug 25, 2025 | |
| RGNX REGENXBIO | Maintains: Outperform | $21 → $17 | $9.84 | +72.76% | 10 | Aug 8, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Outperform | $25 → $21 | $11.51 | +82.53% | 5 | Aug 8, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Outperform | $40 → $38 | $28.35 | +34.04% | 9 | Aug 8, 2025 | |
| ASND Ascendis Pharma | Maintains: Outperform | $210 → $230 | $200.02 | +14.99% | 3 | Aug 8, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Sector Perform | $38 → $42 | $52.69 | -20.29% | 14 | Aug 5, 2025 | |
| FULC Fulcrum Therapeutics | Maintains: Sector Perform | $4 → $5 | $6.52 | -23.31% | 1 | Jul 30, 2025 | |
| DYN Dyne Therapeutics | Maintains: Outperform | $25 → $23 | $13.43 | +71.26% | 3 | Jul 29, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Sector Perform | $5 → $4 | $3.24 | +23.46% | 8 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $1.12 | +792.86% | 9 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $18 | $27.60 | -34.78% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $32 → $28 | $23.50 | +19.15% | 17 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $20 | $4.83 | +314.08% | 5 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $330 | $449.00 | -26.50% | 27 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $105 → $95 | $26.04 | +264.89% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $2 | $0.48 | +320.26% | 6 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $17 | $13.02 | +30.57% | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $13 | $7.33 | +77.47% | 6 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $35 | $6.47 | +440.96% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $24 → $26 | $18.35 | +41.69% | 7 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $70 | $58.47 | +19.73% | 12 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $24 | $17.32 | +38.61% | 6 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $57 | $34.61 | +64.69% | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $67 | $47.75 | +40.31% | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $5 → $4 | $2.49 | +60.64% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $77 | $31.50 | +144.44% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $15 | $7.87 | +90.60% | 5 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $1.88 | +644.68% | 5 | Aug 7, 2024 |
Ionis Pharmaceuticals
Sep 4, 2025
Maintains: Outperform
Price Target: $70 → $80
Current: $60.49
Upside: +32.25%
argenx SE
Aug 25, 2025
Initiates: Outperform
Price Target: $850
Current: $740.13
Upside: +14.84%
REGENXBIO
Aug 8, 2025
Maintains: Outperform
Price Target: $21 → $17
Current: $9.84
Upside: +72.76%
Intellia Therapeutics
Aug 8, 2025
Maintains: Outperform
Price Target: $25 → $21
Current: $11.51
Upside: +82.53%
Arrowhead Pharmaceuticals
Aug 8, 2025
Maintains: Outperform
Price Target: $40 → $38
Current: $28.35
Upside: +34.04%
Ascendis Pharma
Aug 8, 2025
Maintains: Outperform
Price Target: $210 → $230
Current: $200.02
Upside: +14.99%
CRISPR Therapeutics AG
Aug 5, 2025
Maintains: Sector Perform
Price Target: $38 → $42
Current: $52.69
Upside: -20.29%
Fulcrum Therapeutics
Jul 30, 2025
Maintains: Sector Perform
Price Target: $4 → $5
Current: $6.52
Upside: -23.31%
Dyne Therapeutics
Jul 29, 2025
Maintains: Outperform
Price Target: $25 → $23
Current: $13.43
Upside: +71.26%
Adverum Biotechnologies
May 15, 2025
Maintains: Sector Perform
Price Target: $5 → $4
Current: $3.24
Upside: +23.46%
May 14, 2025
Reiterates: Outperform
Price Target: $10
Current: $1.12
Upside: +792.86%
May 8, 2025
Maintains: Sector Perform
Price Target: $21 → $18
Current: $27.60
Upside: -34.78%
May 2, 2025
Maintains: Sector Perform
Price Target: $32 → $28
Current: $23.50
Upside: +19.15%
Mar 25, 2025
Maintains: Outperform
Price Target: $24 → $20
Current: $4.83
Upside: +314.08%
Mar 21, 2025
Maintains: Outperform
Price Target: $310 → $330
Current: $449.00
Upside: -26.50%
Mar 19, 2025
Maintains: Outperform
Price Target: $105 → $95
Current: $26.04
Upside: +264.89%
Mar 18, 2025
Reiterates: Sector Perform
Price Target: $2
Current: $0.48
Upside: +320.26%
Mar 18, 2025
Initiates: Outperform
Price Target: $17
Current: $13.02
Upside: +30.57%
Mar 17, 2025
Maintains: Outperform
Price Target: $11 → $13
Current: $7.33
Upside: +77.47%
Mar 3, 2025
Maintains: Outperform
Price Target: $39 → $35
Current: $6.47
Upside: +440.96%
Feb 26, 2025
Maintains: Sector Perform
Price Target: $24 → $26
Current: $18.35
Upside: +41.69%
Feb 20, 2025
Reiterates: Sector Perform
Price Target: $70
Current: $58.47
Upside: +19.73%
Jan 21, 2025
Reiterates: Outperform
Price Target: $24
Current: $17.32
Upside: +38.61%
Jan 21, 2025
Reiterates: Outperform
Price Target: $57
Current: $34.61
Upside: +64.69%
Jan 21, 2025
Reiterates: Outperform
Price Target: $67
Current: $47.75
Upside: +40.31%
Dec 13, 2024
Maintains: Sector Perform
Price Target: $5 → $4
Current: $2.49
Upside: +60.64%
Nov 6, 2024
Reiterates: Outperform
Price Target: $77
Current: $31.50
Upside: +144.44%
Oct 21, 2024
Maintains: Sector Perform
Price Target: $7 → $15
Current: $7.87
Upside: +90.60%
Aug 7, 2024
Reiterates: Outperform
Price Target: $14
Current: $1.88
Upside: +644.68%